Search Results - "Hiršl, Lea"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Immune responses to congenital cytomegalovirus infection by Brizić, Ilija, Hiršl, Lea, Britt, William J., Krmpotić, Astrid, Jonjić, Stipan

    Published in Microbes and infection (01-10-2018)
    “…Human cytomegalovirus (HCMV) is the most common cause of viral infection acquired in utero. Even though the infection has been studied for several decades,…”
    Get full text
    Journal Article
  3. 3

    Production- and Purification-Relevant Properties of Human and Murine Cytomegalovirus by Ravlić, Sanda, Brgles, Marija, Hiršl, Lea, Jonjić, Stipan, Halassy, Beata

    Published in Viruses (10-12-2021)
    “…There is a large unmet need for a prophylactic vaccine against human cytomegalovirus (HCMV) to combat the ubiquitous infection that is ongoing with this…”
    Get full text
    Journal Article
  4. 4

    CD4 T cells are required for maintenance of CD8 TRM cells and virus control in the brain of MCMV-infected newborn mice by Brizić, Ilija, Hiršl, Lea, Šustić, Marko, Golemac, Mijo, Britt, William J., Krmpotić, Astrid, Jonjić, Stipan

    Published in Medical microbiology and immunology (01-08-2019)
    “…Cytomegalovirus (CMV) infection is a significant public health problem. Congenital CMV infection is a leading infectious cause of long-term neurodevelopmental…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines by Hiršl, Lea, Brizić, Ilija, Jenuš, Tina, Juranić Lisnić, Vanda, Reichel, Johanna Julia, Jurković, Slaven, Krmpotić, Astrid, Jonjić, Stipan

    Published in Frontiers in immunology (07-05-2018)
    “…The development of a vaccine against human cytomegalovirus (CMV) has been a subject of long-term medical interest. The research during recent years identified…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    254 NTX-1088, a potent anti-PVR Mab induces DNAM1-mediated antitumor immunity by Atieh, Anas, Obiedat, Akram, Cinamon, Guy, Rovis, Tihana Lenac, Brlic, Paola Kucan, Hirsl, Lea, Mandelboim, Ofer, Jonjic, Stipan, Paz, Keren, Tsukerman, Pini

    Published in Journal for immunotherapy of cancer (01-11-2021)
    “…BackgroundPoliovirus receptor (PVR, CD155) represents a resistance mechanism to approved immune checkpoint inhibitors (ICIs). It is a key regulator of immune…”
    Get full text
    Journal Article
  10. 10
  11. 11

    CD4 T cells are required for maintenance of CD8 T RM cells and virus control in the brain of MCMV-infected newborn mice by Brizić, Ilija, Hiršl, Lea, Šustić, Marko, Golemac, Mijo, Britt, William J, Krmpotić, Astrid, Jonjić, Stipan

    Published in Medical microbiology and immunology (01-08-2019)
    “…Cytomegalovirus (CMV) infection is a significant public health problem. Congenital CMV infection is a leading infectious cause of long-term neurodevelopmental…”
    Get full text
    Journal Article
  12. 12

    Non-phosphorylated Tyr-1248 form of human epidermal growth factor receptor 2 by Ramie, Snjezana, Balja, Melita Perie, Marton, Ingrid, Knezevie, Fabijan, Smajlbegovie, Velda, Paic, Frane, Hirsl, Lea

    Published in Croatian medical journal (01-04-2022)
    “…Aim To determine the predictive value of phosphorylated human epidermal growth factor receptor 2 ([pHER2.sup.Y1248]) status in breast cancer (BC) patients…”
    Get full text
    Journal Article
  13. 13

    Abstract P102: NTX-1088, A potent first-in-class, anti-PVR mAb, restores expression and function of DNAM1 for optimal DNAM1-mediated antitumor immunity by Tsukerman, Pini, Atieh, Anas, Obeidat, Akram, Paz, Keren, Cinamon, Guy, Roviš, Tihana Lenac, Hirsl, Lea, Brilc, Paola Kucan, Jonjic, Stipan, Mandelboim, Ofer

    Published in Molecular cancer therapeutics (01-12-2021)
    “…Abstract The poliovirus receptor (PVR, CD155) represents a resistance mechanism to approved immune checkpoint inhibitors (ICIs). It is a key regulator of…”
    Get full text
    Journal Article
  14. 14

    474 First-in-class anti-PVR mAb NTX1088 restores expression of DNAM1 and augments antitumor immunity by Obeidat, Akram, Atieh, Anas, Vitenshtein, Alon, Cinamon, Guy, Paz, Keren, Roviš, Tihana, Brilc, Paola, Hirsl, Lea, Mandelboim, Ofer, Jonjic, Stipan, Pini Tsukerman

    Published in Journal for immunotherapy of cancer (01-11-2022)
    “…BackgroundPoliovirus receptor (PVR, CD155) is a novel oncology target, differentially overexpressed in a wide range of solid tumors, which recently emerged as…”
    Get full text
    Journal Article
  15. 15

    Abstract 5534: NTX-1088, a first-in-class anti-PVR mAb mediates DNAM1-dependent antitumor immunity by Obiedat, Akram, Atieh, Anas, Cinamon, Guy, Paz, Keren, Brilc, Paola Kucan, Hirsl, Lea, Roviš, Tihana Lenac, Mandelboim, Ofer, Jonjic, Stipan, Tsukerman, Pini

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Abstract Poliovirus receptor (PVR, CD155), expressed on the surface of cancer cells, represents a resistance mechanism to approved immune checkpoint inhibitors…”
    Get full text
    Journal Article